My Account Log in

1 option

Cardiac Amyloidosis : Diagnosis and Treatment / edited by Michele Emdin, Giuseppe Vergaro, Alberto Aimo, Marianna Fontana.

Springer Medicine eBooks 2024 Available online

View online
Format:
Book
Author/Creator:
Emdin, Michele.
Contributor:
Vergaro, Giuseppe.
Aimo, Alberto.
Fontana, Marianna.
Series:
Medicine Series
Language:
English
Subjects (All):
Medical sciences.
Health Sciences.
Local Subjects:
Health Sciences.
Physical Description:
1 online resource (319 pages)
Edition:
1st ed. 2024.
Place of Publication:
Cham : Springer Nature Switzerland : Imprint: Springer, 2024.
Summary:
Cardiac amyloidosis (CA) is caused by the accumulation of amyloid fibrils in the extracellular space of the myocardium, with clinical manifestations including conduction disturbances and heart failure. CA has traditionally been considered a rare disease, lacking effective therapies and with a poor prognosis, but in recent years, increased possibilities for non-invasive diagnosis and greater awareness of the disease have led to the identification of a growing number of cases, challenging the concept of CA as a rare disease. This is why the ability to recognise and manage patients with CA should become part of the core curriculum of cardiologists, but also of internal medicine specialists, neurologists, nephrologists, haematologists, and general practitioners. This book, written by leading experts in the field, will provide the state-of-the-art in the diagnosis and management of CA and will also discuss the latest research developments and future research directions. The volume appears to be a timely one, given the great interest of clinicians and researchers in CA and the exponential increase in publications in recent year, and will be of interest to cardiologists, internal medicine and other disciplines specialists who may encounter patients with CA in their clinical practice, as well as general practitioners.
Contents:
1. Tribute to Claudio Rapezzi
2. Giampaolo Merlini and the Pavia School
3. A brief history of amyloidosis
4. Pathophysiology, classification and epidemiology of amyloidosis
5. Amyloid light chain (AL) amyloidosis
6. Hereditary transthyretin amyloidosis
7. Wild-type ATTR amyloidosis
8. Electrocardiographic patterns
9. Echocardiography: a gatekeeper to diagnosis
10. Cardiovascular magnetic resonance: characterization of myocardial involvement
11. Biomarkers: monoclonal protein and indicators of cardiac damage
12. Plasma transthyretin and its ligands
13. Cardiac Scintigraphy with Bone-Avid Tracers – Old and New Applications
14. PET-CT: a tool for etiological diagnosis
15. The role of tissue biopsy: identification of the amyloid precursor and beyond
16. From red flags to diagnosis
17. Risk prediction and follow-up
18. Differential diagnoses in clinical mimics
19. Applications of Artificial Intelligence in Amyloidosis
20. Treatment of amyloid light-chain amyloidosis
21. Treatment of ATTR amyloidosis: from stabilizers to gene-editing
22. Treatment of cardiac complications
23. Monitoring disease progression and response to disease-modifying treatments
24. Cardiac amyloidosis: open issues and future perspectives.
Notes:
Description based on publisher supplied metadata and other sources.
ISBN:
3-031-51757-1
OCLC:
1428976120

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account